Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Expression of cancer-testis (CT) antigens in placenta.

Jungbluth AA, Silva WA Jr, Iversen K, Frosina D, Zaidi B, Coplan K, Eastlake-Wade SK, Castelli SB, Spagnoli GC, Old LJ, Vogel M.

Cancer Immun. 2007 Aug 24;7:15.

2.

Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.

Scanlan MJ, Ritter G, Yin BW, Williams C Jr, Cohen LS, Coplan KA, Fortunato SR, Frosina D, Lee SY, Murray AE, Chua R, Filonenko VV, Sato E, Old LJ, Jungbluth AA.

Cancer Immun. 2006 Jan 12;6:2.

3.

Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.

Dhodapkar MV, Osman K, Teruya-Feldstein J, Filippa D, Hedvat CV, Iversen K, Kolb D, Geller MD, Hassoun H, Kewalramani T, Comenzo RL, Coplan K, Chen YT, Jungbluth AA.

Cancer Immun. 2003 Jul 23;3:9.

4.

A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.

Jungbluth AA, Stockert E, Huang HJ, Collins VP, Coplan K, Iversen K, Kolb D, Johns TJ, Scott AM, Gullick WJ, Ritter G, Cohen L, Scanlan MJ, Cavenee WK, Old LJ.

Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):639-44. Epub 2003 Jan 6. Erratum in: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2163. Cavanee, Webster K [corrected to Cavenee, Webster K].

5.

CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues.

Jungbluth AA, Chen YT, Busam KJ, Coplan K, Kolb D, Iversen K, Williamson B, Van Landeghem FK, Stockert E, Old LJ.

Int J Cancer. 2002 Jun 20;99(6):839-45.

6.

MAGE antigen expression in monophasic and biphasic synovial sarcoma.

Antonescu CR, Busam KJ, Iversen K, Kolb D, Coplan K, Spagnoli GC, Ladanyi M, Old LJ, Jungbluth AA.

Hum Pathol. 2002 Feb;33(2):225-9.

PMID:
11957149
7.

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7.

Jungbluth AA, Antonescu CR, Busam KJ, Iversen K, Kolb D, Coplan K, Chen YT, Stockert E, Ladanyi M, Old LJ.

Int J Cancer. 2001 Oct 15;94(2):252-6.

8.

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues.

Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ.

Int J Cancer. 2001 Jun 15;92(6):856-60. Erratum in: Int J Cancer 2002 Feb 20;97(6):878.

9.

Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas.

Jungbluth AA, King R, Fisher DE, Iversen K, Coplan K, Kolb D, Williamson B, Chen YT, Stockert E, Old LJ, Busam KJ.

Appl Immunohistochem Mol Morphol. 2001 Mar;9(1):29-34.

PMID:
11277411
10.

Expression of MAGE antigens and analysis of the inflammatory T-cell infiltrate in human seminoma.

Grobholz R, Verbeke CS, Schleger C, Köhrmann KU, Hein B, Wolf G, Bleyl U, Spagnoli GC, Coplan K, Kolb D, Iversen K, Jungbluth AA.

Urol Res. 2000 Dec;28(6):398-403.

PMID:
11221919
12.

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.

Jungbluth AA, Stockert E, Chen YT, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Busam KJ, Old LJ.

Br J Cancer. 2000 Aug;83(4):493-7.

13.

T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.

Jungbluth AA, Iversen K, Coplan K, Kolb D, Stockert E, Chen YT, Old LJ, Busam K.

Pathol Res Pract. 2000;196(4):235-42.

PMID:
10782467
14.

Expression of MAGE-antigens in normal tissues and cancer.

Jungbluth AA, Busam KJ, Kolb D, Iversen K, Coplan K, Chen YT, Spagnoli GC, Old LJ.

Int J Cancer. 2000 Feb 15;85(4):460-5.

15.

Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis.

Jungbluth AA, Iversen K, Coplan K, Williamson B, Chen YT, Stockert E, Old LJ, Busam KJ.

Virchows Arch. 1999 May;434(5):429-35.

PMID:
10389626
16.

Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.

Busam KJ, Chen YT, Old LJ, Stockert E, Iversen K, Coplan KA, Rosai J, Barnhill RL, Jungbluth AA.

Am J Surg Pathol. 1998 Aug;22(8):976-82.

PMID:
9706977
17.

A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.

Jungbluth AA, Busam KJ, Gerald WL, Stockert E, Coplan KA, Iversen K, MacGregor DP, Old LJ, Chen YT.

Am J Surg Pathol. 1998 May;22(5):595-602.

PMID:
9591730
18.

Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.

Barendswaard EC, Scott AM, Divgi CR, Williams C Jr, Coplan K, Riedel E, Yao TJ, Gansow OA, Finn RD, Larson SM, Old LJ, Welt S.

Int J Oncol. 1998 Jan;12(1):45-53.

PMID:
9454885
19.

Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors.

Busam KJ, Iversen K, Coplan KA, Old LJ, Stockert E, Chen YT, McGregor D, Jungbluth A.

Am J Surg Pathol. 1998 Jan;22(1):57-63.

PMID:
9422316
20.

Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas.

Chen YT, Stockert E, Jungbluth A, Tsang S, Coplan KA, Scanlan MJ, Old LJ.

Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5915-9.

21.

Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.

Chen YT, Stockert E, Tsang S, Coplan KA, Old LJ.

Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8125-9.

22.

HLA expression in hepatocellular carcinoma cell lines.

Wadee AA, Paterson A, Coplan KA, Reddy SG.

Clin Exp Immunol. 1994 Aug;97(2):328-33.

23.

Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.

Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH Jr, Mendelsohn J.

J Natl Cancer Inst. 1993 Aug 18;85(16):1327-33.

PMID:
8340945

Supplemental Content

Loading ...
Support Center